White-matter abnormalities in presymptomatic GRN and C9orf72 mutation carriers

被引:3
|
作者
Lee, Hyunwoo [1 ]
Mackenzie, Ian R. A. [2 ]
Beg, Mirza Faisal [3 ]
Popuri, Karteek [4 ]
Rademakers, Rosa [5 ,6 ,7 ]
Wittenberg, Dana [1 ]
Hsiung, Ging-Yuek Robin [1 ]
机构
[1] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 2B5, Canada
[2] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada
[3] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC V5A 1S6, Canada
[4] Mem Univ Newfoundland, Dept Comp Sci, St John, NL A1B 3X5, Canada
[5] VIB, VIB Ctr Mol Neurol, Appl & Translat Neurogen, B-2610 Antwerp, Belgium
[6] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium
[7] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA
关键词
frontotemporal dementia; MRI; white matter; GENETIC FRONTOTEMPORAL DEMENTIA; HUMAN CEREBRAL-CORTEX; GRAY-MATTER; BRAIN; PROGRANULIN; HYPERINTENSITIES; DEGENERATION; INTEGRITY; ATROPHY; GENFI;
D O I
10.1093/braincomms/fcac333
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lee et al. report that MRI-based white-matter abnormalities are more pronounced in presymptomatic GRN and C9orf72 mutation carriers, compared with family controls who do not carry the mutations. They suggest that white-matter changes may represent early markers of familial frontotemporal dementia associated with a genetic cause. A large proportion of familial frontotemporal dementia is caused by TAR DNA-binding protein 43 (transactive response DNA-binding protein 43 kDa) proteinopathies. Accordingly, carriers of autosomal dominant mutations in the genes associated with TAR DNA-binding protein 43 aggregation, such as Chromosome 9 open reading frame 72 (C9orf72) or progranulin (GRN), are at risk of later developing frontotemporal dementia. Brain imaging abnormalities that develop before dementia onset in mutation carriers may serve as proxies for the presymptomatic stages of familial frontotemporal dementia due to a genetic cause. Our study objective was to investigate brain MRI-based white-matter changes in predementia participants carrying mutations in C9orf72 or GRN genes. We analysed mutation carriers and their family member controls (noncarriers) from the University of British Columbia familial frontotemporal dementia study. First, a total of 42 participants (8 GRN carriers; 11 C9orf72 carriers; 23 noncarriers) had longitudinal T-1-weighted MRI over similar to 2 years. White-matter signal hypointensities were segmented and volumes were calculated for each participant. General linear models were applied to compare the baseline burden and the annualized rate of accumulation of signal abnormalities among mutation carriers and noncarriers. Second, a total of 60 participants (9 GRN carriers; 17 C9orf72 carriers; 34 noncarriers) had cross-sectional diffusion tensor MRI available. For each participant, we calculated the average fractional anisotropy and mean, radial and axial diffusivity parameter values within the normal-appearing white-matter tissues. General linear models were applied to compare whether mutation carriers and noncarriers had different trends in diffusion tensor imaging parameter values as they neared the expected age of onset. Baseline volumes of white-matter signal abnormalities were not significantly different among mutation carriers and noncarriers. Longitudinally, GRN carriers had significantly higher annualized rates of accumulation (estimated mean: 15.87%/year) compared with C9orf72 carriers (3.69%/year) or noncarriers (2.64%/year). A significant relationship between diffusion tensor imaging parameter values and increasing expected age of onset was found in the periventricular normal-appearing white-matter region. Specifically, GRN carriers had a tendency of a faster increase of mean and radial diffusivity values and C9orf72 carriers had a tendency of a faster decline of fractional anisotropy values as they reached closer to the expected age of dementia onset. These findings suggest that white-matter changes may represent early markers of familial frontotemporal dementia due to genetic causes. However, GRN and C9orf72 mutation carriers may have different mechanisms leading to tissue abnormalities.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Epilepsy and electroencephalographic abnormalities in C9orf72 repeat expansion
    Capasso, Margherita
    Anzellotti, Francesca
    Di Giacomo, Roberta
    Onofrj, Marco
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2017, 18 (1-2) : 140 - 141
  • [32] Electrical impedance myography (EIM) in a natural history study of C9ORF72 mutation carriers
    Offit, Michelle B.
    Wu, Tianxia
    Floeter, Mary Kay
    Lehky, Tanya J.
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2020, 21 (5-6) : 445 - 451
  • [33] Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia
    Tang, Min
    Gu, Xiaohua
    Wei, Jingya
    Jiao, Bin
    Zhou, Lin
    Zhou, Yafang
    Weng, Ling
    Yan, Xinxiang
    Tang, Beisha
    Xu, Jun
    Shen, Lu
    NEUROBIOLOGY OF AGING, 2016, 46 : 235.e11 - 235.e15
  • [34] Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients
    Guven, Gamze
    Lohmann, Ebba
    Bras, Jose
    Gibbs, J. Raphael
    Gurvit, Hakan
    Bilgic, Basar
    Hanagasi, Hasmet
    Rizzu, Patrizia
    Heutink, Peter
    Emre, Murat
    Erginel-Unaltuna, Nihan
    Just, Walter
    Hardy, John
    Singleton, Andrew
    Guerreiro, Rita
    PLOS ONE, 2016, 11 (09):
  • [35] Mutation analysis of C9orf72 in patients with corticobasal syndrome
    Anor, Cassandra J.
    Xi, Zhengrui
    Zhang, Ming
    Moreno, Danielle
    Sato, Christine
    Rogaeva, Ekaterina
    Tartaglia, Maria Carmela
    NEUROBIOLOGY OF AGING, 2015, 36 (10) : 2905.e1 - 2905.e5
  • [36] Frequency of C9orf72, GRN, and MAPT pathogenic variants in patients recruited at the Belgrade Memory Center
    Stefanova, Elka
    Marjanovic, Ana
    Dobricic, Valerija
    Mandic-Stojmenovic, Gorana
    Stojkovic, Tanja
    Brankovic, Marija
    Sarcevic, Maksim
    Novakovic, Ivana
    Kostic, Vladimir S.
    NEUROGENETICS, 2024, 25 (03) : 193 - 200
  • [37] Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers
    Le Blanc, Gabriella
    Pomerleau, Vincent Jette
    McCarthy, Jillian
    Borroni, Barbara
    van Swieten, John
    Galimberti, Daniela
    Sanchez-Valle, Raquel
    LaForce, Robert, Jr.
    Moreno, Fermin
    Synofzik, Matthis
    Graff, Caroline
    Masellis, Mario
    Tartaglia, Maria C.
    Rowe, James B.
    Vandenberghe, Rik
    Finger, Elizabeth
    Tagliavini, Fabrizio
    de Mendonca, Alexandre
    Santana, Isabel
    Butler, Chris
    Gerhard, Alex
    Danek, Adrian
    Levin, Johannes
    Otto, Markus
    Frisoni, Giovanni
    Sorbi, Sandro
    Rohrer, Jonathan D.
    Ducharme, Simon
    ANNALS OF NEUROLOGY, 2020, 88 (01) : 113 - 122
  • [38] Limbic Network and Papez Circuit Involvement in ALS: Imaging and Clinical Profiles in GGGGCC Hexanucleotide Carriers in C9orf72 and C9orf72-Negative Patients
    Christidi, Foteini
    Kleinerova, Jana
    Tan, Ee Ling
    Delaney, Siobhan
    Tacheva, Asya
    Hengeveld, Jennifer C.
    Doherty, Mark A.
    Mclaughlin, Russell L.
    Hardiman, Orla
    Siah, We Fong
    Chang, Kai Ming
    Lope, Jasmin
    Bede, Peter
    BIOLOGY-BASEL, 2024, 13 (07):
  • [39] Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype
    Origone, Paola
    Accardo, Jennifer
    Verdiani, Simonetta
    Lamp, Merit
    Arnaldi, Dario
    Bellone, Emilia
    Picco, Agnese
    Morbelli, Silvia
    Mandich, Paola
    Nobili, Flavio
    NEUROCASE, 2015, 21 (04) : 529 - 534
  • [40] Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene
    van Blitterswijk, Marka
    Mullen, Bianca
    Wojtas, Aleksandra
    Heckman, Michael G.
    Diehl, Nancy N.
    Baker, Matthew C.
    DeJesus-Hernandez, Mariely
    Brown, Patricia H.
    Murray, Melissa E.
    Hsiung, Ging-Yuek R.
    Stewart, Heather
    Karydas, Anna M.
    Finger, Elizabeth
    Kertesz, Andrew
    Bigio, Eileen H.
    Weintraub, Sandra
    Mesulam, Marsel
    Hatanpaa, Kimmo J.
    White, Charles L., III
    Neumann, Manuela
    Strong, Michael J.
    Beach, Thomas G.
    Wszolek, Zbigniew K.
    Lippa, Carol
    Caselli, Richard
    Petrucelli, Leonard
    Josephs, Keith A.
    Parisi, Joseph E.
    Knopman, David S.
    Petersen, Ronald C.
    Mackenzie, Ian R.
    Seeley, William W.
    Grinberg, Lea T.
    Miller, Bruce L.
    Boylan, Kevin B.
    Graff-Radford, Neill R.
    Boeve, Bradley F.
    Dickson, Dennis W.
    Rademakers, Rosa
    MOLECULAR NEURODEGENERATION, 2014, 9 : 38